Buy or sell Recursion Pharmaceuticals stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Recursion Pharmaceuticals Stock

Artificial intelligence to discover treatments

Founded

2013

Notable Investors

Menlo Ventures

Headquarters

Salt Lake City UT, US

Total Funding

$206M

About Recursion Pharmaceuticals Stock

Recursion Pharmaceuticals is a biotechnology company based in Salt Lake City. Recursion Pharmaceuticals combines experimental biology, automation, and artificial intelligence in a massively parallel system to quickly and efficiently identify treatments for any disease which can be modeled at the cellular level. From its initial and continued focus on drug repurposing to treat rare diseases, Recursion Pharmaceuticals has broadened its platform to probe rich data from high-throughput automated screens for a number of indications, including aging, inflammation, infectious disease, and immunology. Recursion Pharmaceuticals is aggressively leveraging technology to build a robust and reliable map of human cellular biology, which will enable a radical shift in the pace and scale at which new treatments will benefit patients.

Investors

Funding History

September 2016$3.5M
September 2016$21.4M
October 2017$60.1M
February 2019$121M

Management

Co-Founder and Chief Technology Officer

Blake Borgeson

Co-Founder and Chief Executive Officer

Chris Gibson

Co-Founder

Dean Li

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Recursion Pharmaceuticals or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 80K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo